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PENUBUHAN MODEL MUKOSA MULUT 3D MENGGUNAKAN 
SEL STEM DARIPADA GIGI SUSU MANUSIA TERKELUPAS 




Mukosa oral merupakan sejenis tisu khusus yang melapisi rongga mulut. Ia 
terdiri daripada dua lapisan utama: epitelium skuamos berstratum dan lamina propria. 
Lapisan epitelium terdiri daripada sel-sel epitelium, manakala lapisan lamina propria 
kebanyakannya terdiri daripada fibroblas. Perkara yang dititikberatkan dalam mukosa 
oral in vitro adalah, pembentukan model ini hendaklah dijalankan mengikut seni bina 
ketebalan sepenuhnya menggunakan kedua-dua sel tersebut. Oleh itu, kajian ini 
bertujuan untuk membezakan sel stem daripada gigi susu manusia yang terkelupas 
(SHED) kepada sel seperti fibroblas dan epitelium yang seterusnya akan digunakan 
dalam pembentukan model mukosa oral 3D. Pembezaan SHED telah dijalankan 
dengan melibatkan faktor pertumbuhan, yang dinamakan faktor pertumbuhan tisu 
penghubung (CTGF) untuk pembezaan fibroblas, manakala faktor pertumbuhan 
keratinosit (KGF), faktor pertumbuhan epidermis (EGF), faktor pertumbuhan 
hepatosit (HGF), dan faktor pertumbuhan seperti insulin-2 (IGF-II) telah digunakan 
bagi pembezaan epitelium. Pencirian terhadap sel terinduksi dilakukan melalui 
pemerhatian morfologi, kadar proliferasi, analisis pengekspresan gen dan protein 
dengan menggunakan tindak balas berantai polimerase transkriptase balik selangkah 
secara semi-kuantitatif (sqRT-PCR), pewarnaan imunopendarfluor, dan sitometri 




menggabungkan kolagen/kitosan/kondroitin sulfat/asid hialuronik (100/12/5/1) secara 
menyeluruh. Perancah berliang yang terhasil telah dicirikan melalui integriti 
penstrukturan, ketelapan, dan ketumpatan. Sel-sel terbeza yang telah dicirikan 
seterusnya dikultur bersama di atas perancah CGC untuk membentuk model mukosa 
oral 3D, yang kemudiannya dicirikan melalui histologi dan analisis imunopendarfluor. 
Keputusan menunjukkan kesan induktif faktor pertumbuhan terhadap sel seperti 
fibroblas dan epitelium yang terbeza daripada SHED. Sel seperti fibroblas secara 
morfologinya adalah sama dengan SHED, manakala sel seperti epitelium menyerupai 
sel epitelium asli. Analisis statistik menggunakan ANOVA sehala terhadap pengasaian 
proliferasi telah menunjukkan korelasi yang signifikan (p<0.05) di antara sel yang 
terinduksi dengan faktor-faktor pertumbuhan yang terlibat. Terdapat perbezaan yang 
signifikan dalam pengekspresan gen dan protein di antara SHED dengan sel-sel 
terbeza. Satu perancah CGC putih, liofilisasi berliang yang terhasil mampu 
mengekalkan integriti pengstrukturan dan ianya tidak mengalami degradasi sepanjang 
keseluruhan eksperimen. Perancah juga menunjukkan ketelapan dan ketumpatan yang 
baik. Sistem kultur bersama telah menunjukkan bahawa sel seperti fibroblas dan 
epitelium yang diperolehi daripada SHED berupaya untuk melekat dan membiak 
apabila dikultur di atas perancah CGC. Hasil pewarnaan hematoksilin dan eosin 
(H&E) terhadap model mukosa oral juga menunjukkan infiltrasi dan stratifikasi sel 
seperti fibroblas dan epitelium pada beberapa kawasan di dalam perancah CGC. 
Penghasilan kolagen turut dapat diperhatikan melalui pewarnaan Masson Trichrome. 
Pewarnaan imunopendarfluor terhadap sel seperti epitelium yang didapati di dalam 
perancah CGC membuktikan kehadiran sel tersebut. Oleh itu, penemuan ini telah 
menyediakan satu pemahaman baharu terhadap potensi SHED dalam pembentukan 




ESTABLISHMENT OF 3D ORAL MUCOSA MODEL USING 
DIFFERENTIATED STEM CELLS FROM HUMAN 




Oral mucosa is a specialized type of tissue that lines the oral cavity. It consists 
of two main layers: stratified squamous epithelium and lamina propria. The epithelial 
layer is resided by the epithelial cells, while the lamina propria layer is majorly 
occupied by fibroblasts. As far as the in vitro oral mucosa is concerned, the 
construction of an oral mucosa model should be performed in full thickness 
architecture using both cells mentioned. Therefore, the present study aimed to 
differentiate stem cells from human exfoliated deciduous teeth (SHED) into fibroblast- 
and epithelial-like cells to be subsequently used in the establishment of a 3D oral 
mucosa model. The differentiation of SHED was carried out by the involvement of 
growth factors, namely connective tissue growth factor (CTGF) for fibroblastic 
differentiation, whereas keratinocyte growth factor (KGF), epidermal growth factor 
(EGF), hepatocyte growth factor (HGF) and insulin-like growth factor-2 (IGF-II) were 
employed in epithelial differentiation, respectively. The characterisation of the 
induced cells was done by morphological observation, proliferation rate, gene and 
protein expression analyses using semi-quantitative reverse transcription-polymerase 
chain reaction (sqRT-PCR), immunofluorescence staining and flow cytometry. The 
collagen-glycosaminoglycan-chitosan (CGC) scaffold was constructed by combining 




porous scaffold produced was characterized via their structural integrity, porosity, and 
density. The characterized differentiated cells were then co-cultured on CGC scaffold 
to generate a 3D oral mucosa model, which was later characterized via histological 
and immunofluorescence analyses. The results demonstrated the inductive effect of 
growth factors in both fibroblastic and epithelial differentiation of SHED. SHED 
derived-fibroblast-like cells are morphologically similar to SHED, while SHED 
derived-epithelial-like cells resembled native epithelial cells. Statistical analysis using 
one-way ANOVA of the proliferation assay showed a significant correlation (p<0.05) 
between the induced cells and growth factors involved. There were significant 
differences in gene and protein expressions between SHED and both differentiated 
cells. A white, porous lyophilized CGC scaffold produced was able to maintain its 
structural integrity and did not degrade throughout the whole experiments. The 
scaffold also exhibited good porosity and density. The co-culture system showed that 
the fibroblast- and epithelial-like cells derived from SHED were able to attach and 
proliferate when being seeded on CGC scaffold. The haematoxylin and eosin (H&E) 
staining of the established oral mucosa model also exhibited the infiltration and 
stratification of the fibroblast- and epithelial-like cells in some regions within CGC 
scaffolds. Also, the production of collagen could be observed via the Masson 
Trichrome staining. The immunofluorescence staining of the epithelial-like cells 
grown in the CGC scaffold also supported the presence of those cells. These findings 
hence provide a new understanding on the potential of SHED in the establishment of 








1.1 Background of the study 
 
Oral cavity is a unique anatomical environment comprised of specialized tissues and 
fluids necessary for the initial food intake and speech, taste processing, as well as other 
sensory perceptions (McArthur, 1998). It refers to the space from the lips to the end of 
the hard palate (Courey and Pletcher, 2016). In the human body, the development of 
oral cavity occurs roughly about four weeks from the stomatodeum during the folding 
of the embryo in the head-tail line (Schroeder, 1991; Pelissier et al., 1992; Nanci, 
2017).  
 
Anatomically, oral cavity is lined by a mucous membrane known as oral mucosa. Oral 
mucosa is comprised of two layers: (i) the stratified squamous epithelium (outer layer) 
which is attached to (ii) dense connective tissue/lamina propria (underlying layer) at 
the basement membrane. Both of these epithelial and dense connective tissue layers 
show different structural modifications in different regions of the oral cavity.  
 
Going inside the structural modification of the epithelial layer, it is originally lined by 
a single layer of epithelial cells and gradually develops another two layers which takes 
approximately five to six weeks. Soon after, the extracellular fibres are secreted by the 
sparsely populated ectomesenchyme. By ten weeks, a multilayer of the epithelial cells 




Deeper to the epithelial layer overlies the dense connective tissue, which is also known 
as the lamina propria layer. This layer provides support for the epithelial cell layer 
(Schroeder, 1991; Winning and Townsend, 2000). This connective tissue is originally 
from ectomesenchyme, particularly the neural crest cells that migrate from anterior 
rhombomeres and the midbrain to the relevant branchial arches and developing facial 
region (Johnston and Bronsky, 1995; Winning and Townsend, 2000).  
 
As far as the mucosal defects are concerned, loss of integrity of the oral mucosa due 
to trauma a result of oral cavity tumour resections (Eckardt et al., 2011), acute or 
chronic infections, diseases, injuries (Hafizah et al., 2017), as well as cleft lip and 
palate is commonly reported particularly in the developing country. If this problem is 
left untreated, it could result in loss of water and proteins in the oral mucosa, leading 
to bacterial invasion in the oral mucosa (Liu et al., 2010) and in due course, may cause 
the crucial dysfunction and aesthetic defect of the oral cavity.  
 
Since decades ago, the oral mucosa defects have been reconstructed using guided 
tissue replacement, skin/autologous graft, vestibuloplasty (Izumi et al., 2015), root 
coverage technique (Liu et al., 2010), and many others. Unfortunately, the 
reconstructions have been challenged with the difficulty of finding an appropriate and 
acceptable source of the autologous grafts or transplantations. Therefore, as another 
alternative treatment, the development of oral mucosa in vitro using the tissue 
engineering approach has been extensively highlighted. 
 
Tissue engineering is defined as an interdisciplinary field that applies the principles of 




restore, maintain, or improve tissue function or a whole organ (Langer and Vacanti, 
1993). It also denotes the development of a device in the laboratory, containing 
biological mediators (e.g. growth factors) and viable cells in a biological or synthetic 
matrix that could be implanted in patients to expedite the regeneration of specific 
tissues (Jaquery, 2007). Tissue engineering restores tissues that have been impaired 
either by trauma, injury, or disease by activating signal transduction pathways and 
mimicking the microenvironment. The regeneration of tissues should be engineered 
practically so that the regenerated tissues are as closely similar as native tissues in 
nature. Although researches involving this approach was carried out since early 1900s, 
the term “tissue engineering” was only officially coined at National Science 
Foundation workshop in 1988 (Akter, 2016). In 1991, the term was first recorded in 
an article entitled “Functional Organ Replacement: The New Technology of Tissue 
Engineering” in “Surgical Technology International” (Vacanti and Vacanti, 1991).  
 
Until this date, abundant experimental and clinical studies have been done involving 
this approach. As far as the cost of therapy is concerned, as of the end of 2018, tissue 
engineering therapies have been marketed in the range of $400 in South Korea to 
$123,154 in Japan. The autologous cell therapies have cost around $61,500 in the 
United Kingdom to $169,206 in the United States. Whereas, gene therapies have been 
marketed around $5,501 for tonogenchoncel-L in South Korea and $1,398,321 for 
alipogene tiparvovec in Germany. Approximately $2,150 to $200,000 is for allogenic 
cell therapies in India and Canada, respectively (Shukla et al., 2019). Although it is 
still not known how it will impact the regenerative dentistry field in the future, 
somehow with progressive approach in this field, it is expected to solve various health 




By focusing on the tissue engineering approach, the present study aimed on the 
differentiation of SHED with the involvement of growth factors to be grown on a 
scaffold-based 3D culture for the development of full thickness 3D oral mucosa model. 
The scaffold-based 3D culture is known to be anchorage-dependent featuring the cells 
to be embedded into the matrix. The growth of cells inside this scaffold-based 3D 
culture could provide an appropriate microenvironment for cell growth, optimal 
function, differentiation, as well as the ability to create tissue‐like assemblies in vitro. 
In the present investigation, naturally-derived CGC scaffold has become a candidate 
of interest in the development of a 3D oral mucosa model as it has been shown to give 
out good fibroblasts-epithelial cells interactions and therefore, is able to produce a 
highly differentiated non-keratinized full thickness oral mucosa model with good 
multilayer stratified epithelium (Moharamzadeh et al., 2007; 2012).  
 
As far as the cell is concerned, the selection of SHED in the development of oral 
mucosa model is due to the fact that SHED did demonstrate the highest proliferation 
(Miura et al., 2003) and differentiation capability (Jeon et al., 2014) compared to that 
in other dental stem cells as well as human bone marrow-derived mesenchymal stem 
cells (BMMSCs). Moreover, the use of SHED provides an alternative to embryonic 
stem cells, where their use has been proved controversial.  
 
The success of SHED differentiation in this study would enhance further knowledge 
on the SHED behaviour and their ability to be used in the future development of tissue-






1.2 Justification of the study 
 
In the oral cavity, reconstructions after tumour resection, vestibuloplasty, surgical 
closure of a cleft palate or treatment of gingival recessions require suitable grafting 
materials. Oral mucosa is limited in supply and the use of skin grafts in the oral cavity 
has some disadvantages. The keratinized surface of the grafted skin tends to macerate 
and is easily infected by fungi. Furthermore, hair growth may also occur after the 
transplantation into the oral cavity. Other problems include risk of donor site 
morbidity, inadequate tissue sources, cost, patient, surgical procedure, and time 
constraint. To overcome this problem, modelling of oral mucosa has been a major goal 
of the recent studies. Several in vitro tissue-engineered oral mucosa models have been 
developed, but no ultimate, standardized models are established neither for partial 
thickness nor full thickness oral mucosa models.  
 
Apart from medical therapy, tissue-engineered oral mucosa models are being 
increasingly used to measure toxicity, drug delivery, as well as to investigate oral 
diseases. Currently, oral mucosa models are mainly comprised of normal oral 
keratinocytes cultured on top of a normal oral fibroblasts-containing matrix. However, 
the commercial supply of oral mucosa models is limited, restricting widespread use of 
these mucosa models. In addition, it also suffers from poor longevity and donor-to-
donor variability. 
 
Hence, this study, by using tissue engineering approach, embarked on the induction 
and assembly of SHED-derived-fibroblast- and epithelial-like cells in order to study 




of SHED into fibroblast- and epithelial-like cells was expected to reduce the constraint 
of getting tissues from biopsies for oral mucosa reconstruction as well as eliminate the 
associated problems, thus making it a promising model in future regenerative dentistry. 
 
1.3 Research objectives 
 
1.3.1 General objective 
 
This study aimed to establish a 3D oral mucosa model using fibroblast- and epithelial-
like cells of SHED seeded on CGC scaffold. 
 
1.3.2 Specific objectives 
 
To achieve the aim of the study, several specific objectives were defined as follows: 
 
1. To induce and characterize fibroblast-like cells from SHED by morphological 
and proliferation characteristic, gene and protein expressions. 
2. To induce and characterize epithelial-like cells from SHED by morphological 
and proliferation characteristic, gene and protein expressions. 
3. To construct and characterize scaffold using collagen, glycosaminoglycan, and 
chitosan (CGC). 
4. To establish and characterize 3D oral mucosa model on CGC scaffold by co-







1.4 Research questions 
 
1. Do SHED have the ability to differentiate into fibroblast-like cells? 
2. Do SHED have the ability to differentiate into epithelial-like cells? 
3. Can collagen, glycosaminoglycan, and chitosan be constructed into a good 
scaffold?  
4. Do fibroblast- and epithelial-like cells derived from SHED have the ability to 
be co-cultured and exhibit oral mucosa architecture on CGC scaffold in the 
construction of a 3D oral mucosa model?  
 
1.5 Research hypotheses 
 
1. The fibroblast- and epithelial-like cells differentiated from SHED show 
significant differences in morphology, proliferation, gene and protein 
expressions compared to SHED. 
2. It is possible to establish a 3D oral mucosa model using differentiated cells 
















2.1 Anatomy of oral mucosa 
 
Oral mucosa is a mucous membrane lining the oral cavity. Anatomically, it is located 
between the skin of the outer face and the mucosal lining of the gastrointestinal tract. 
It is about 500 mm in depth (Nanci and Ten Cate, 2003), with keratinized mucosa 
significantly thinner than non-keratinized mucosa (Gordon et al., 1968; Markiewicz et 
al., 2007). The structure of oral mucosa is more similar to the skin compared to any 
other mucosa in the body, which acts as a barrier against the external factors such as 
thermal, chemical, mechanical and biological damage (Izumi et al., 2015), as well as 
protection from entry of toxic materials and microorganisms (Squier and Kremer, 
2001) (Figure 2.1). 
 
Oral mucosa is basically comprised of two main specialized tissue layers; the thick 
stratified epithelia overlying a thin lamina propria, in which they are divided by the 
undulating basement membrane (Figure 2.2). The epithelial layer forms the outer 
surface of oral mucosa which creates a barrier between the oral environment and 
deeper tissues. Therefore, when there is a disease or injury to oral mucosa, the 
epithelial layer is usually most affected. Underneath the epithelial layer is the lamina 
propria which consists of reticular and papillary layer. Structurally, reticular layer is 
prominent in lining mucosa whereas papillary layer is prominent in masticatory 






Figure 2.1 Anatomy of the human oral mucosa (Adapted from Cook et al., 2017) 
 
 
The structural modifications of the epithelium and connective tissue in distinct regions 
of the oral cavity provide three recognizable histological classifications, i.e. 
masticatory mucosa (keratinized mucosa), lining mucosa (non-keratinized mucosa), 
and specialized mucosa (both keratinized and non-keratinized mucosa). Although the 
keratinized mucosa is less permeable than the non-keratinized mucosa, however, it is 







Figure 2.2 A micrograph showing the histology of oral mucosa. It consists of two 
main specialized tissue layers: a) the epithelial layer which is comprised 
of epithelial cells, and b) lamina propria layer which consists of nerves, 
blood, and lymphatic vessels, as well as multiple types of cells such as 
fibroblasts, defence cells, and other extracellular matrices (ECM). Scale 
bar = 100 μm. Magnification is 200X  
 
 
The masticatory mucosa is the tough area which is involved with the mechanical forces 
during mastication, such as gingiva and hard palate. This area occupies 25% of the oral 
cavity (Collins and Dawes, 1987; Squier and Kremer, 2001) and is lined mostly by 
thick ortho-keratinized epithelium (Granado, 2012), although areas of para-keratinized 
epithelium might be seen. The lining mucosa, which is lined by soft and non-
keratinized epithelium takes up 60% of the oral cavity (Collins and Dawes, 1987; 
Squier and Kremer, 2001). It covers the soft palate, alveolar processes, floor of mouth, 




2015). This type of mucosa does not function in mastication and hence has little 
attrition.  
 
The specialized mucosa is found at the dorsum of tongue and occupies 15% of the total 
cavity (Collins and Dawes, 1987; Squier and Kremer, 2001). This area is lined by both 
keratinized and non-keratinized epithelia depending on the keratinization that occurs 
on the papillae of the dorsum of the tongue. For example, the fungiform, circumvallate, 
and filiform papillae at the dorsal surface of the tongue are lined by keratinized 
epithelium, whereas the inter-papillary regions are lined by non-keratinized epithelium 
(Winning and Townsend, 2000). Although it is considered as masticatory mucosa by 
function, this type of mucosa is also categorized as specialized mucosa due to their 
cornified epithelial papillae (Granado, 2012) and high extensibility characteristic.  
 
From this, it could be understood that although it covers oral cavity, there are variations 
in the types of oral mucosa which are based on their main role in oral cavity. Thus, in 
any case of tissue regeneration, the ideal replacement would be from tissue origin. 
 
2.1.1 Epithelial layer  
 
The epithelial layer of oral mucosa is comprised of the tightly packed epithelial cells 
originated from ectodermal embryonic germ layer (Figure 2.2a) (Kolltveit et al., 2010; 
Queiroz et al., 2010), except the tongue which arises from both ectoderm and 
endoderm (Winning and Townsend, 2000; Rothova et al., 2012). They appear to be 
stratified squamous-shaped and small in size (Figure 2.3). Apart from the epithelial 




Merkel cells, Langerhans cells, lymphocytes, as well as melanocytes (Winning and 
Townsend, 2000). The thickness of the epithelial layer varies depending on the 
location in the oral cavity. For example, the epithelial layer in the floor of the mouth 
is very thin, i.e. only 190 ± 40 μm, while the epithelial layer of the hard palate is about 
310 ± 50 μm. Whereas, the cheek mucosa has the thickest epithelial layer compared to 
these two regions, which is around 580 ± 90 μm (Schroeder, 1981; Kinikoglu, 2010). 
The differences in the thickness of this epithelial layer could be due to the fact that the 
keratinized mucosa turnover is slower than that in the non-keratinized mucosa (Rowat 
and Squier, 1986). 
 
 
Figure 2.3 Morphology of the epithelial cells in vitro. The cells appear stratified 






The oral mucosa epithelial layer consists of four distinct layers with different degrees 
of differentiation, namely the stratum basale, stratum spinosum, stratum granulosum, 
and stratum corneum (Figure 2.2a). The stratum basale contains basal cells that are 
cuboidal in shape and smallest in size termed as basal cells. In this layer also resides a 
small population of the least differentiated, quiescent, and highly proliferative cells 
(Papini et al., 2003; Calenic et al., 2010). Cells from this layer divide, differentiate, 
and migrate towards the surface, into the stratum spinosum. As they move into the 
stratum spinosum, these cells increase in size and change in shape to appear ‘prickly’, 
hence are termed as prickle cells. The prickly appearance is due to high number of 
attachment that allows cells to interact with each other. These prickle cells migrate to 
the surface and become flatten, and the intensely staining granules at this layer give 
the characteristic appearance to stratum granulosum. These granules are known as 
keratohyalin granules. Finally, at or near the surface of the epithelium, as the granular 
cells migrate, they lose a lot of their structures and disintegrate into the oral cavity 
having the keratinized layer on the surface of oral mucosa as part of stratum corneum. 
However, this layer is absent in non-keratinized mucosa. 
 
In view of keratinization, it is a maturation process that occurs in keratinocytes, a type 
of cells that are generated when the epithelial cells of the epithelial layer renew 
themselves and undergo cell turnover, which occurs approximately 25 days in the 
cheek and 41-75 days in the gingiva. In this process, the keratinocytes are produced 
by the mitotic division in the stratum basale and progress towards to the surface of the 
epithelium where they are shed off (Deo and Deshmush, 2018). The maturation could 
occur in different extents and types, which is either non-keratinization, para-




location in the oral cavity. Although these non-keratinized and keratinized epithelia 
are derived from the same germ layer, however, they express different sets of keratin, 
a protein that forms the intermediate filaments of cytoskeleton. For instance, the non-
keratinized epithelia of oral mucosa express K4, K5, K13, K14, and K19, whereas the 
keratinized epithelia of oral mucosa express K1, K2, K5, K6, K10, K14, and K16 
(Clausen et al., 1986; Winning and Townsend, 2000; Moharamzadeh et al., 2007; 
Kinikoglu, 2010). 
 
With regards to their sources in in vitro studies, the epithelial cells could be collected 
from different areas in the body such as skin and oral mucosa biopsy (buccal mucosa, 
hard palate, and gingiva). Usually, the collection of these epithelial cells requires 
minor surgery which could be a painful and invasive process. However, they could 
also be obtained from other sources including adipose stem cells which could be 
induced to differentiate into BMMSCs, keratinocytes, umbilical cord stem cells, 
induced pluripotent stem cells (iPSCs), and embryonic stem cells (Liu et al., 2011).  
 
2.1.2 Lamina propria/connective tissue layer  
 
The lamina propria or connective tissue layer is composed of numerous types of cells 
and fibres that are embedded in ground substances of glycoproteins and proteoglycans. 
This layer is majorly resided by fibroblasts, although defence cells (macrophages, 
lymphocytes), mast cells, plasma cells, blood vessels, nerves, as well as other ECM 
also exist (Figure 2.2b). The fibroblasts demonstrate the appearance of elongated cells 
with extended cell processes and thus, give out the spindle-like form (Figure 2.4). 




and are known to be the least specialized type of connective tissue. They were also 
suggested to possess the foetal-tissue-like phenotypes (Sloan, 1991; Lee and Eun, 
1999), which denote the foetal fibroblast subpopulations that have gone through the 
clonal expansion (Irwin et al., 1994; Stephens et al., 1996).  
 
The fibroblasts function by depositing and degrading the collagen fibres, namely 
collagen type I, III, V, and VI in the ECM of connective tissues (Tomasek et al., 2002; 
Driskell & Watt, 2015), in which the collagen fibres in the non-keratinized mucosa are 




Figure 2.4 Morphology of the human gingival fibroblasts in vitro. The cells appear 





They also play a major role in homeostasis and wound healing of tissue (Häkkinen et 
al., 2014). Fibroblasts facilitate the morphogenesis of the epithelium which is 
evidenced by a study that showed the absence of fibroblasts in the matrix terminated 
the proliferation of epithelial cells (Fusenig, 1994; Hafizah et al., 2017) while 
continued the differentiation of epithelial cells (Smola et al., 1998; Hafizah et al., 
2017). Moreover, they also influence the epithelial phenotypes and profile expressions 
of the cytokeratins with regard to their origin and nature. Any disturbance in activation 
and proliferation of fibroblasts could lead to the devastating circumstances, namely 
cancer and fibrosis (Kalluri & Zeisberg, 2006). 
 
With regard to the use of these fibroblasts in cell culture study, there are no specific 
guidelines regarding the optimal passage range. However, a previous study reported 
that the fibroblasts were better to be used at early passage and less than 30 population 
doublings (Chen et al., 2013). In fact, the use of early passage is important to mimic 
the in vivo environment more closely. Besides, the production of the ECM will 
decrease as the passage number of fibroblasts increases.  
 
In addition, the late passage fibroblasts were reported to lead to the ageing of the cells, 
thus causing them to lose its proper functionality (Chen et al., 2013; Kwist et al., 
2016). This phenomenon later will affect the proliferation rates, carrier-mediated 
transport activities, metabolic activities, cell densities, as well as transport and toxicity 
of exogenous and endogenous compounds (Briske-Anderson et al., 1997; Ranaldi et 
al., 2003; Hughes et al., 2007). There will be decrement of RNA turnover with 
increment of intracellular content of RNA and protein as a result of reduced protein 




with the ECM or expression of secreted proteins which eventually increase the 
sensitivity of the cell contact (Cristofalo and Pignolo, 1993; Chen et al., 2013). 
 
2.2 Defects related to oral mucosa  
 
Oral mucosa defects can affect people of any age, gender, and background. The 
majority of oral mucosa defect could primarily be due to the trauma, a result of oral 
cavity tumour resection (Eckardt et al., 2011; Le et al., 2014), cleft lip and palate, as 
well as chronic infection causing gingival defect such as in chronic periodontitis 
(Franz-Montan et al., 2017). Any diseases or injuries to oral mucosa can lead to 
impairment of the oral functions and aesthetics. If left untreated, it will lead to the loss 
of integrity of the oral mucosa. Added to this problem, the limited capability of adult 
humans to regenerate after large tissue damage/loss will give greater impact to the 
structural dysfunction of the oral mucosa.  
 
2.3 Treatment related to oral mucosa defects and development of oral mucosa 
model 
 
Different approaches have been employed for the reconstruction of oral mucosa 
defects: from autologous/skin graft, epithelial sheet culture, to tissue-engineered three-
dimensional (3D) oral mucosa model. For decades, oral mucosa defects have been 
reconstructed using autologous/skin grafts. This approach involved the cells collected 
from various parts of the oral cavity, including gingiva, hard or soft palate, and buccal 
surface. This approach was considered as the gold standard in craniofacial 




(autologous), therefore it provided no risk of immune rejections. However, this model 
has been limited by tissue site morbidity since it leaves defects at the donor site, and it 
is difficult to harvest enough oral mucosa for reconstruction. In addition, the 
periodontal and oral maxillofacial surgeons have been frequently confronted with the 
problem of finding an acceptable and appropriate source of the transplantations or 
autologous grafts. The tendency of the skin grafts’ keratinized surface to fungi 
infection, hair growth, and maceration following oral transplantation also need to be 
taken into consideration (Liu et al., 2010). There are several other disadvantages 
including time constraint and cost problems (Izumi et al., 2015). Another technique 
also used autologous tissue from the outside of oral cavity such as skin, however, it 
may not be able to lose its original characteristics and therefore, may give out its 
phenotype in the grafted site, e.g. the growth of hair in the oral mucosa where the skin 
tissue is grafted.  
 
Due to those limitations, the researchers then started to fabricate the epithelial sheet. 
This model, which was established in dental researches since the 1990s uses only one 
type of cell layer, i.e. oral epithelial cells obtained from small oral biopsies. This 
approach is suitable especially in the study of the basic phenomena and biology of the 
oral mucosa, treatment of oesophageal ulcerations (Ohki et al., 2006), as well as for 
cornea, trachea, skin and urinary bladder regeneration (Takagi et al., 2012). The 
epithelial sheet culture made use of several techniques, including culturing on 
temperature-responsive culture dishes (Okano et al., 1993), on human amniotic 
membranes (Nakamura et al., 2003), and on collagen membranes (Imaizumi et al., 




contraction, was easily fragile, and difficult to manipulate with low engraftment rates 
(Feinberg et al., 2005).  
 
As an alternative treatment to overcome the limitations associated with the epithelial 
sheet culture, the oral mucosa model has been developed with the advancement of 
tissue-engineered 3D culture. This model has been developed for the purpose of in 
vitro studies of basic oral biological interactions, biocompatibility tests, understanding 
oral diseases and mucosal irritations, drug delivery studies, as well as for clinical 
applications. Oral mucosa model was developed prior to 2006, since then numerous 
studies have reported the development of 3D oral mucosa model with modification in 
cell sources, scaffolds, and media.  
 
The architecture of tissue-engineered 3D oral mucosa model could be distinguished 
based on its thickness. The partial thickness model usually employs only the epithelial 
layer. This type of model is not suitable for advanced studies since it does not provide 
the anatomical structure of native oral mucosa. The structures obtained by partial 
thickness oral mucosa model form the basis for full thickness oral mucosa engineering. 
The full thickness model usually consists of epithelial and mesenchymal/connective 
layers. This model demonstrates a better simulation of the in vivo situation as it 
resembles normal oral mucosa as closely as possible. Several studies have reported 
successful assembly of full thickness human oral mucosa by culturing oral 
keratinocytes with fibroblasts on collagen (Moriyama et al., 2001; Rouabhia and 
Deslauriers, 2002) or on the de-epidermized dermis (Cho et al., 2000; Bhargava et al., 
2004). As far as the native oral mucosa composite is concerned, the construction of 




thickness architecture using the fibroblasts and epithelial cells to mimic the native oral 
mucosa.  
 
2.4 Tissue engineering and its key elements 
 
Tissue engineering is defined as an interdisciplinary field that applies the principles of 
engineering and life sciences towards the development of biological substitutes that 
restore, maintain, or improve tissue function or a whole organ (Langer and Vacanti, 
1993). It implies the construction of a device containing viable cells and biological 
mediators such as the growth factors in a synthetic or biological matrix that could be 
implanted in patients to facilitate the regeneration of particular tissues (Jaquery, 2007).  
 
The basic principle of the tissue engineering triad has three pillars; the signalling 
molecules (growth factors), scaffolds (biomaterials), and cells (Mhanna and Hasan, 
2017) (Figure 2.5). The process involves culturing cells on the biodegradable scaffolds 
in an optimal environment containing signalling molecules such as growth factor. 
Since each pillar in the triad of tissue engineering has a wide range of elements, the 
selection of appropriate scaffolds, signalling molecules, and methodologies is very 








Figure 2.5 The triad of tissue engineering. The three pillars use combination of the 
signalling molecules (growth factors), scaffolds (biomaterials), and 
cells. The functionality of the cells could be influenced by the 




2.4.1 Signalling molecules 
 
Signalling molecules such as growth factors are polypeptides derived from cytokine 
family (Goustin et al., 1986) which bind to specific cell membrane receptors with high 
affinity (Sherbet, 2011). According to the previous studies regarding the mechanisms 




grouping or classification of growth factors by far. However, based on several basic 
features, growth factors could be divided into several groups; (1) families, (2) species 
and (3) signalling pathways (Sherbet, 2011). 
 
Growth factors generally function to up-regulate or down-regulate cell activities. 
These biochemical factors are responsible in the induction of cellular survival, 
inflammation, differentiation, growth, as well as tissue repair (Sherbet, 2011). They 
function as critical tools in regulating the neurite outgrowth, tissue morphogenesis, 
and angiogenesis. In addition, they also act as signalling molecules by means of 
binding to transmembrane receptors which contain cytoplasmic tyrosine kinase 
domains (Li and Hristove, 2010). The effect of this growth factor-receptor interaction 
sends morphogenic signals to the cells in order to stimulate the biological functions of 
cells. 
 
Although the growth factors can be easily obtained and scaled up for major production, 
there are concerns regarding possible pathological side effects of the growth factors 
(Rose and Oreffo, 2002; Aravamudhan et al., 2013). The long-term use may affect the 
efficacy, stability, and activity of these growth factors. This is due to the fact that the 
majority of the growth factors are synthesized in the prokaryotic systems such as 
Escherichia coli via recombinant DNA technology. Therefore, there is a difference in 
the synthesized growth factor in prokaryotic systems and the human body since the 
prokaryotic systems usually do not undergo the post-translational modifications, e.g. 





Every cell type will respond differently to different growth factor, as they may have 
different signalling pathways to achieve certain actions. Due to this reason, the 
selection of appropriate growth factors is a critical factor for the induction of cell 
differentiation. 
 
2.4.2 Growth factor for fibroblastic differentiation 
 
To this date, there is dearth of studies reported on the differentiation of stem cells into 
fibroblast-like cells. Even to the best of available knowledge, there are only a few 
growth factors reported to be used in fibroblastic differentiation from various cells, 
such as CTGF (Lee et al., 2006), EGF, and bone morphogenic protein-4 (BMP-4) 
(Hewitt et al., 2011). The present literature focuses only on CTGF, for this growth 
factor was selected in this study. 
 
2.4.2 (a) Connective tissue growth factor 
 
CTGF is a member of the CCN cysteine-rich protein family. This 349-amino acid 
polypeptide (Bradham et al., 1991), with a molecular weight of 38-kDa (Aikawa et al., 
2006) exhibits highly conserved disulphide bonding pattern (Holbourn et al., 2008). It 
was first discovered in 1991 by Bradham and his colleagues through the screening of 
a HUVEC cDNA expression library using a polyclonal anti-PDGF antibody (Bradham 
et al., 1991). Also, in the same year, the mouse CTGF (Fisp12/βIG-M2) was 
successfully isolated from transforming growth factor-beta (TGF-β)-stimulated mouse 
AKR-2B cells by Brunner et al. (1991), as well as from serum-stimulated NIH 3T3 




Uniquely, CTGF does not behave like a cytokine or traditional growth factor, but more 
as a matricellular protein. This is because, this so-called CCN2 (Lipson et al., 2012) 
does not bind to any specific receptors in order to transduce the signals. However, it 
does cause a change in cellular phenotype by modulating the cell-matrix interactions 
(Chen et al., 2001; Shi-wen et al., 2008).  
 
2.4.3 Growth factors for epithelial differentiation 
 
Within the epithelial cells, there is a collective process known as cellular migration 
which could influence the metastasis, development, remodelling, and wound healing 
(Khalil and Friedl, 2010). Such cellular cooperative movement is regulated by both 
biochemical signalling as well as physical interaction with neighbouring cells and 
underlying substrates, particularly intercellular stresses at cell-to-cell adhesion sites 
and traction forces at cell-substrate adhesion sites (Maruthamuthu et al., 2011). Due 
to this reason, therefore, it is very crucial in this study to select the appropriate growth 
factors for the epithelial differentiation of SHED. Previous studies have reported the 
differentiation of SHED into epithelial cells using different means, such as cultured in 
serum-free KGF (Nam and Lee, 2009) and with the involvement of TGF-β1 (Azmi, 
2017). As for this research, multiple combinations of growth factors were selected, 
namely KGF, HGF, EGF, and IGF-II. 
 
2.4.3 (a) Keratinocyte growth factor 
 
KGF belongs to a fibroblast growth factor (FGF) family with 30-45% homologous to 
other seven members of the FGF family (Finch et al., 1989). This 18.9 kDa growth 
